Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Provias

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Neurosurgery|October 18, 2019
Hypertrophic Interstitial Neuropathy of the Trigeminal Nerve: Case Report and Literature ReviewAlick P Wang, Dragos Catana, John P Provias, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 7, 2014
Statin-associated Autoimmune Myopathies: A Pathophysiologic SpectrumYufan Wu, Boleslaw Lach, John P Provias, et al.
Oncogene|November 8, 2019
A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cellsBranavan Manoranjan, Chirayu Chokshi, Chitra Venugopal, et al.
Acta Neuropathologica Communications|December 19, 2021
De novo pathogenic variant in SETX causes a rapidly progressive neurodegenerative disorder of early childhood-onset with severe axonal polyneuropathyAristides Hadjinicolaou, Kathie J Ngo, Daniel Y Conway, et al.
Stem Cell Research|January 24, 2012
Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cellsChitra Venugopal, Na Li, Xin Wang, et al.
Acta Neuropathologica Communications|November 30, 2016
The identification of human pituitary adenoma-initiating cellsBranavan Manoranjan, Sujeivan Mahendram, Saleh A Almenawer, et al.
Journal of the National Cancer Institute|February 19, 2013
A cancer stem cell model for studying brain metastases from primary lung cancerSara M Nolte, Chitra Venugopal, Nicole McFarlane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2015
Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating CellsChitra Venugopal, Robin Hallett, Parvez Vora, et al.
Nature Communications|August 30, 2020
Wnt activation as a therapeutic strategy in medulloblastomaBranavan Manoranjan, Chitra Venugopal, David Bakhshinyan, et al.
Acta Neuropathologica|September 30, 2022
The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory driversNazanin Tatari, Shahbaz Khan, Julie Livingstone, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Neurosurgery|October 18, 2019
Hypertrophic Interstitial Neuropathy of the Trigeminal Nerve: Case Report and Literature ReviewAlick P Wang, Dragos Catana, John P Provias, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 7, 2014
Statin-associated Autoimmune Myopathies: A Pathophysiologic SpectrumYufan Wu, Boleslaw Lach, John P Provias, et al.
Oncogene|November 8, 2019
A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cellsBranavan Manoranjan, Chirayu Chokshi, Chitra Venugopal, et al.
Acta Neuropathologica Communications|December 19, 2021
De novo pathogenic variant in SETX causes a rapidly progressive neurodegenerative disorder of early childhood-onset with severe axonal polyneuropathyAristides Hadjinicolaou, Kathie J Ngo, Daniel Y Conway, et al.
Stem Cell Research|January 24, 2012
Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cellsChitra Venugopal, Na Li, Xin Wang, et al.
Acta Neuropathologica Communications|November 30, 2016
The identification of human pituitary adenoma-initiating cellsBranavan Manoranjan, Sujeivan Mahendram, Saleh A Almenawer, et al.
Journal of the National Cancer Institute|February 19, 2013
A cancer stem cell model for studying brain metastases from primary lung cancerSara M Nolte, Chitra Venugopal, Nicole McFarlane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2015
Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating CellsChitra Venugopal, Robin Hallett, Parvez Vora, et al.
Nature Communications|August 30, 2020
Wnt activation as a therapeutic strategy in medulloblastomaBranavan Manoranjan, Chitra Venugopal, David Bakhshinyan, et al.
Acta Neuropathologica|September 30, 2022
The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory driversNazanin Tatari, Shahbaz Khan, Julie Livingstone, et al.
Pageof 3